GLPG-1690
-
Catalog numberB1850-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile
-
DescriptionGLPG-1690 is a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease (IPF).
-
CAS Number1628260-79-6
-
Structure AvailableYes
-
Molecular FormulaC₃₀H₃₃FN₈O₂S
-
Molecular Weight588.7
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA selective autotaxin inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID90420193
-
SMILESCCC1=C(N2C=C(C=C(C2=N1)C)N3CCN(CC3)CC(=O)N4CC(C4)O)N(C)C5=NC(=C(S5)C#N)C6=CC=C(C=C6)F
-
InChiInChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3
-
InChi KeyREQQVBGILUTQNN-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGLPG-1690
-
Alternative nameGLPG-1690
-